Mengis Capital Management, Inc. Silk Road Medical Inc Transaction History

Mengis Capital Management, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$11.38 - $19.03 $1,422 - $2,378	-125 Reduced 1.21%	10,225 $187,000
Q4 2023 Feb 01, 2024	SELL	$6.29 - $15.72 $17,234 - $43,072	-2,740 Reduced 20.93%	10,350 $126,000
Q3 2023 Nov 09, 2023	SELL	$14.99 - $32.65 $4,497 - $9,795	-300 Reduced 2.24%	13,090 $196,000
Q2 2023 Aug 08, 2023	BUY	$29.76 - $46.14 $17,260 - $26,761	580 Added 4.53%	13,390 $435,000
Q1 2023 May 05, 2023	BUY	$38.09 - $57.79 $487,932 - $740,289	12,810 New	12,810 $501,000
Q2 2022 Jul 19, 2022	BUY	$28.03 - $45.8 $17,518 - $28,625	625 Added 5.28%	12,460 $453,000
Q1 2022 May 02, 2022	SELL	$29.24 - $44.06 $7,310 - $11,015	-250 Reduced 2.07%	11,835 $488,000
Q3 2021 Nov 03, 2021	SELL	$44.0 - $65.8 $4,400 - $6,580	-100 Reduced 0.82%	12,085 $665,000
Q1 2021 May 07, 2021	SELL	$46.31 - $62.7 $11,577 - $15,675	-250 Reduced 2.01%	12,185 $617,000
Q4 2020 Feb 03, 2021	BUY	$55.51 - $69.94 $102,693 - $129,389	1,850 Added 17.48%	12,435 $783,000
Q3 2020 Oct 29, 2020	SELL	$42.19 - $69.61 $4,219 - $6,961	-100 Reduced 0.94%	10,585 $711,000
Q2 2020 Jul 22, 2020	BUY	$27.55 - $43.28 $8,265 - $12,984	300 Added 2.89%	10,685 $447,000
Q1 2020 May 06, 2020	BUY	$23.16 - $47.8 $8,106 - $16,730	350 Added 3.49%	10,385 $326,000
Q4 2019 Feb 06, 2020	BUY	$27.97 - $40.38 $280,678 - $405,213	10,035 New	10,035 $405,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mengis Capital Management, Inc. with notifications on news.